SCHEMBL25534612

SCHEMBL25534612

c1ccc(-c2nc(-c3ccccc3-c3ccccc3)cc(-c3ccc(-c4ccc5c(c4)C(c4ccccc4)(c4ccccc4)c4ccccc4-5)c4ccccc34)n2)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 4/20 0.36
KMT2A Q03164 4/20 0.36
MAPT P10636 4/20 0.36
ALDH1A1 P00352 2/20 0.36
HPGD P15428 2/20 0.36
NTSR1 P30989 1/20 0.36
LMNA P02545 3/20 0.35
KDM4E B2RXH2 2/20 0.35
SMN1; SMN2 Q16637 2/20 0.35
OPRK1 P41145 1/20 0.35
PDK2 Q15119 5/20 0.35
MAOB P27338 3/20 0.34
POLB P06746 1/20 0.33
MAOA P21397 1/20 0.33
GLA P06280 1/20 0.33
GPR55 Q9Y2T6 1/20 0.33
RARB P10826 1/20 0.32
RARG P13631 1/20 0.32
RXRA P19793 1/20 0.32
MAPK1 P28482 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25534767 0.96 PDK2 (0.35) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25534725 0.96 PDK2 (0.39) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL26183218 0.96 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25534967 0.95 MEN1 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25534821 0.95 PDK2 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25538132 0.94 MEN1 (0.37) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25538130 0.94 PDK2 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25534833 0.94 PDK2 (0.38) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25534666 0.94 MEN1 (0.40) MEN1KMT2AMAPTALDH1A1HPGD
SCHEMBL25534624 0.94 MEN1 (0.43) MEN1KMT2AMAPTALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO.,LTD. (JP) 2023-06-01 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230167072-A1 COMPOUND, MATERIAL FOR ORGANIC ELECTROLUMINESCENT ELEMENTS, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE PIEZO1, LEF1, L1CAM MEN1 267/4885KMT2A 1094/4885MAPT 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.